M.3243A>G: Many faces of one single point mutation

被引：0
|
作者：
Martin Windpessl
Manfred Wallner
Stephan R. Lederer
Thomas Klopstock
Helmut Schiffl
机构：
[1] Klinikum Wels-Grieskirchen,Interne Abteilung
[2] KfH Nierenzentrum,undefined
来源：
Wiener klinische Wochenschrift | 2010年 / 122卷
关键词：
Peritoneal Dialysis; Renal Replacement Therapy; Mitochondrial Disorder; Single Point Mutation; Renal Manifestation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：601 / 602
页数：1
相关论文
共 50 条
  • [21] Independent origin for m.3243A>G mitochondrial mutation in three Venezuelan cases of MELAS syndrome
    Florez, Ingrid
    Pirrone, Irune
    Casique, Liliana
    Luisa Dominguez, Carmen
    Mahfoud, Antonieta
    Rodriguez, Tania
    Rodriguez, Daniel
    De Lucca, Marisel
    Luis Ramirez, Jose
    CLINICAL BIOCHEMISTRY, 2022, 109 : 98 - 101
  • [22] Assessment of the phenotype genotype variability and correlation in m.3243A>G mutation carriers requires prospective studies
    Finsterer, Josef
    Zarrouk-Mahjoub, Sinda
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2016, 8 : 33 - 33
  • [23] Clinical and Molecular Characteristics in 100 Chinese Pediatric Patients with m.3243A>G Mutation in Mitochondrial DNA
    Xia Chang-Yu
    Liu Yu
    Liu Hui
    Zhang Yan-Chun
    Ma Yi-Nan
    Qi Yu
    中华医学杂志英文版, 2016, 129 (16) : 1945 - 1949
  • [24] Isolated mitochondrial myopathy due to m.3243A > G mutation in MT-TL1 gene
    Rohan R. Mahale
    Jyothi Gautham
    Pooja Mailankody
    Hansashree Padmanabha
    P. S. Mathuranath
    Acta Neurologica Belgica, 2022, 122 : 1115 - 1116
  • [25] Neurodegenerative and functional signatures of the cerebellar cortex in m.3243A > G patients
    Haast, Roy A. M.
    De Coo, Irenaeus F. M.
    Ivanov, Dimo
    Khan, Ali R.
    Jansen, Jacobus F. A.
    Smeets, Hubert J. M.
    Uludag, Kamil
    BRAIN COMMUNICATIONS, 2022, 4 (01)
  • [26] Quantification of gait in mitochondrial m.3243A > G patients: a validation study
    Rob Ramakers
    Saskia Koene
    Jan T Groothuis
    Paul de Laat
    Mirian CH Janssen
    Jan Smeitink
    Orphanet Journal of Rare Diseases, 12
  • [27] Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation
    Smeitink, Jan
    van Es, Just
    Bosman, Brigitte
    Janssen, Mirian C. H.
    Klopstock, Thomas
    Gorman, Grainne
    Vissing, John
    Ruiterkamp, Gerrit
    Edgar, Chris J.
    Abbink, Evertine J.
    van Maanen, Rob
    Pogoryelova, Oksana
    Stendel, Claudia
    Bischoff, Almut
    Karin, Ivan
    Munshi, Mahtab
    Kummel, Anne
    Burgert, Lydia
    Verhaak, Christianne
    Renkema, Herma
    BRAIN, 2025, 148 (03) : 896 - 907
  • [28] Intra-patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation
    de Laat, Paul
    Rodenburg, Richard J.
    Smeitink, Jan A. M.
    Janssen, Mirian C. H.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (02):
  • [29] How the most common mitochondrial DNA mutation (m.3243A>G) vanishes from leukocytes: a mathematical model
    Veitia, Reiner A.
    HUMAN MOLECULAR GENETICS, 2018, 27 (09) : 1565 - 1571
  • [30] Fulminant cerebral venous thrombosis associated with the m.3243A>G MELAS mutation: A new guise for an old disease
    Nikolaus, Marc
    Tietze, Anna
    Schweizer, Leonille
    Kaindl, Angela M.
    Stenzel, Werner
    Schuelke, Markus
    Knierim, Ellen
    BRAIN & DEVELOPMENT, 2019, 41 (10): : 901 - 904
12345